FdaApplication

NDA 021938

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCP PHARMACEUTICALS INTERNATIONAL CV
application_typeNDA
approval_date2006-01-26

Products (4)

ProductActive ingredientStrengthDosage form
SUTENTSUNITINIB MALATEEQ 12.5MG BASECAPSULE;ORAL
SUTENTSUNITINIB MALATEEQ 25MG BASECAPSULE;ORAL
SUTENTSUNITINIB MALATEEQ 50MG BASECAPSULE;ORAL
SUTENTSUNITINIB MALATEEQ 37.5MG BASECAPSULE;ORAL

4 products